Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
4.580
+0.120 (2.69%)
At close: Jun 6, 2025, 4:00 PM
4.512
-0.068 (-1.48%)
After-hours: Jun 6, 2025, 5:11 PM EDT
Xeris Biopharma Holdings Employees
Xeris Biopharma Holdings had 394 employees as of December 31, 2024. The number of employees increased by 17 or 4.51% compared to the previous year.
Employees
394
Change (1Y)
17
Growth (1Y)
4.51%
Revenue / Employee
$564,850
Profits / Employee
-$114,406
Market Cap
733.51M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
XERS News
- 3 days ago - Xeris Unveils Strategy for Long-Term Growth and Value Creation at 2025 Analyst & Investor Day - Business Wire
- 17 days ago - Xeris Announces Details for Analyst & Investor Day - Business Wire
- 4 weeks ago - Xeris Biopharma Holdings, Inc. (XERS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Xeris Biopharma Reports Record First Quarter 2025 Financial Results - Business Wire
- 4 weeks ago - Xeris Biopharma Holdings: Looking For More Growth In Q1 Earnings - Seeking Alpha
- 5 weeks ago - Xeris Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025 - Business Wire
- 2 months ago - Xeris Announces Changes to Its Board of Directors - Business Wire
- 2 months ago - Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid - Business Wire